Overview

Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen

Status:
Completed
Trial end date:
2021-01-07
Target enrollment:
Participant gender:
Summary
Phase 3b, open-label single-arm study in which all subjects receive HTX-011 as part of a scheduled non-opioid MMA regimen.
Phase:
Phase 3
Details
Lead Sponsor:
Heron Therapeutics
Treatments:
Acetaminophen
Analgesics
Bupivacaine
Celecoxib
Ibuprofen